King Review spotlight on Hepatitis C meds

Access to very expensive drugs such as Hepatitis C medicines are one of several issues raised in the Pharmacy Remuneration and Regulation Review discussion paper, which examines the way payments for the drugs are made.Among the 140 questions are three inquiring into whether the current arrangements could or should be improved.A recent AJP poll showed